Maura Rosenfeld

Maura Rosenfeld is a C-level, early-stage healthcare investment and business development executive. After spending the first 15 years of her career in commercial law, she found my passion in healthcare innovation. Rosenfeld has vast international experience with healthcare startups, spanning almost 20 years. She is currently the Chief Business Officer of DermAb.io, which has developed a predictive model for response to biologic drugs, starting in autoimmune diseases, which affect women with higher prevalence and greater treatment challenges. Beyond her role in DermAb.io, and as a breast cancer thriver, she takes every opportunity to advocate for women’s health!